Management of Psychiatric Disease in Hepatitis C Treatment Candidates

Por Lotrich, Francis
Publicado em 2010

Gene-environment interactions in geriatric depression

Por Lotrich, Francis E.
Publicado em 2011

Major depression during interferon-α treatment: vulnerability and prevention

Por Lotrich, Francis E.
Publicado em 2009

Psychiatric Clearance for Patients Started on Interferon-Alpha-Based Therapies

Por Lotrich, Francis E.
Publicado em 2013

Inflammatory cytokine-associated depression

Por Lotrich, Francis E
Publicado no Brain Res (2014)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors

Por Lotrich, Francis E, Pollock, Bruce G
Publicado em 2005

Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications

Por Felger, Jennifer C., Lotrich, Francis E.
Publicado em 2013

Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Por McNamara, Robert K, Lotrich, Francis E
Publicado em 2012

Brain-Derived Neurotrophic Factor Serum Levels and Genotype: Association with Depression during Interferon-α Treatment

Por Lotrich, Francis E, Albusaysi, Salwa, Ferrell, Robert E
Publicado em 2013

Elevated Ratio of Arachidonic acid to Long-Chain Omega-3 Fatty Acids Predicts Depression Development Following Interferon-alpha Treatment: Relationship with Interleukin-6

Por Lotrich, Francis E., Sears, Barry, McNamara, Robert K.
Publicado em 2012

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids

Por Lotrich, Francis E., Sears, Barry, McNamara, Robert K.
Publicado em 2013

Polyunsaturated Fatty Acids Moderate the Effect of Poor Sleep on Depression Risk

Por Lotrich, Francis E., Sears, Barry, McNamara, Robert K.
Publicado no Prostaglandins Leukot Essent Fatty Acids (2015)

Depression following pegylated interferon-alpha: characteristics and vulnerability

Por Lotrich, Francis E., Rabinovitz, Mordechai, Gironda, Patricia, Pollock, Bruce G.
Publicado em 2007

Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism

Por Lotrich, Francis E., Ferrell, Robert E., Rabinovitz, Mordechai, Pollock, Bruce G.
Publicado em 2008

Cytokine-induced depression during IFN-α treatment: the role of IL-6 and sleep quality

Por Prather, Aric A., Rabinovitz, Mordechai, Pollock, Bruce G., Lotrich, Francis E.
Publicado em 2009

Labile anger during interferon-alpha treatment is associated with a polymorphism in tumor necrosis factor-alpha

Por Lotrich, Francis E., Ferrell, Robert E., Rabinovitz, Mordechai, Pollock, Bruce G.
Publicado em 2010

Depression in Late-Life: a Focus on Prevention

Por Okereke, Olivia I., Lyness, Jeffrey M., Lotrich, Francis E., Reynolds, Charles F.
Publicado em 2013

IL28B Polymorphism Is Associated with Both Side Effects and Clearance of Hepatitis C During Interferon-Alpha Therapy

Por Lotrich, Francis E., Loftis, Jennifer M., Ferrell, Robert E., Rabinovitz, Mordechai, Hauser, Peter
Publicado em 2011

Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment

Por Franzen, Peter L., Buysse, Daniel J., Rabinovitz, Mordechai, Pollock, Bruce G., Lotrich, Francis E.
Publicado em 2010

Age, MELD Score, And Organ Functioning Predict Post-Transplant Tacrolimus Neurotoxicity

Por DiMartini, Andrea, Fontes, Paulo, Dew, Mary Amanda, Lotrich, Francis E., DeVera, Michael
Publicado em 2008